Company page

Diamedica Therapeutics Inc.

Diamedica Therapeutics Inc. (ticker: DMAC) is a public company based in the United States, focusing on developing innovative therapies for neurological diseases. With a market capitalization of approximately $315.2 million, Diamedica is committed to advancing its research and product pipeline to address unmet medical needs in the healthcare sector.